Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the
diagnosis of Parkinson's disease (PD). We aim to systematically review the diagnostic …

Positron emission tomography (PET) is a non-invasive imaging technology that can reveal
molecular alterations in the brains of Alzheimer's disease (AD) patients with high sensitivity …

Introduction Computational models yield valuable insights into biological interactions not
fully elucidated by experimental approaches. This study investigates an innovative …

Abstract Background Large-scale preclinical Alzheimer's disease study based on β-amyloid
positron emission tomography (PET) has not been conducted in China. Objectives Establish …

Background Alzheimer's disease (AD) is one of the world's well-known neurodegenerative
diseases, which is related to the balance mechanism of production and clearance of two …

Medical imaging has its earliest roots in 1895 when Wilhelm Roentgen discovered X-ray,
providing physicians with the first approach to image internal conditions of human body [1] …

Novel design solutions for dedicated portable brain positron emission tomography systems
with improved performance facilitate emergency and interventional image-guided surgery as …

Mild cognitive impairment (MCI) is often at high risk of progression to Alzheimer's disease
(AD). Existing works to identify the progressive MCI (pMCI) typically require MCI subtype …

The progress in human disease treatment can be greatly advanced through the
implementation of nanomedicine. This approach involves targeted and cell-specific therapy …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects both
cognition and non-cognition functions. The disease follows a continuum, starting with …